QuantRx Biomedical
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income.

Profit Margin

QuantRx Biomedical Corporation (OTC:QTXB): Profit margin
2013 6.11K -358.33K -5861.79%
2014 2.43K -826.98K -34032.3%
2015 156 -467.78K -299858.97%
2016 0 -397.99K
2017 0 869.13K
2018 0 -736.85K
2019 0 -820.10K
2020 0 -469.45K
2021 0 -476.70K
2022 0 0

QTXB Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
00000001562.43K6.11K
Cost of revenue
0000010.85K7.17K9.66K1.97K586
Gross profit
00000-10.85K-7.17K-9.50K4525.52K
Operating exp.
Research and development
000000013.15K65.73K27.91K
Selling and marketing
00000075.43K000
Total operating expenses
043.38K60.62K201.73K235.87K165.17K138.83K358.86K462.93K382.48K
Operating income
0-43.38K-60.62K-201.73K-235.87K-165.17K-138.83K-358.70K-462.48K-376.96K
Other income (expenses), net
0-216.65K-192.11K-420.18K-269.93K1.03M-63.00K-109.07K-364.50K100.88K
Income before tax
0-260.04K-252.73K-621.92K-736.85K869.13K-397.99K-467.78K-826.98K-358.33K
Income tax expense
0216.65K216.72K198.18K601.23K1.27M196.14K123.89K104.68K182.90K
Net income
0-476.70K-469.45K-820.10K-736.85K869.13K-397.99K-467.78K-826.98K-358.33K
Earnings per share
Basic EPS
0-0.00-0.00-0.01-0.000.01-0.00-0.00-0.01-0.00
Diluted EPS
0-0.00-0.00-0.01-0.000.00-0.00-0.00-0.01-0.00
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source